In patients with diabetic nephropathy (DN), WTAP is highly expressed, and WTAP knockdown inhibits the m6A methylation of NLRP3 mRNA to downregulate NLRP3 inflammasome activation, which further induces cell pyroptosis and inflammation 127. Here, WTAP is linked to diabetic kidney disease.